Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...
Novo Nordisk recently made headlines petitioning FDA to stop the compounding of its blockbuster GLP-1 products so it can sell its patented semaglutide drugs exclusively. Compounding is the practice of ...
Still life of Ozempic and Wegovy. Both are injectable prescription weight loss medicines. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) As demand surges for semaglutide ...
Pharmacists and doctors can make compounded medications by combining, mixing, or altering various ingredients to meet a specific need. But because these medications don’t have Food and Drug ...
Through Hubron’s established distributor network, HydroGraph expects expanded access to key markets including automotive, construction, electronics, film, pipe, wire and cable, and technical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results